Back
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. Vs. Novartis AG Industry Stock Comparison
Sell
41
AEF
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC.
Last Price:
$5.07
Seasonality Move:
1.63%
Buy
62
NVSEF
Novartis AG
Last Price:
$109.00
Seasonality Move:
5.79%
Sell
41
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. (AEF)
is a Sell
Is ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. a Buy, Sell or Hold?
-
The current ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. [AEF] share price is $5.09. The Score for AEF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
AEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $109.00. The Score for NVSEF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AEF Stock Price Chart
What is ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC.'s stock price today?
-
The ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. share price today is $5.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AEF is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.00The current trend is moderately bearish and NVSEF is experiencing buying pressure, which is a positive indicator for future bullish movement.
AEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 39.87 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.15 - 5.51) | Sell |
Bollinger Bands (100): | (5.2 - 5.48) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.7 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | 5487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.67 - 112.23) | Buy |
Bollinger Bands (100): | (98.63 - 109.37) | Buy |
AEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.1 | Sell |
20-day SMA: | 5.3 | Sell |
50-day SMA: | 5.3 | Sell |
200-day SMA: | 5.34 | Sell |
8-day EMA: | 5.13 | Sell |
20-day EMA: | 5.23 | Sell |
50-day EMA: | 5.3 | Sell |
200-day EMA: | 5.3 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.29 | Sell |
20-day SMA: | 109.25 | Sell |
50-day SMA: | 103.73 | Buy |
200-day SMA: | 106.3 | Buy |
8-day EMA: | 112.15 | Sell |
20-day EMA: | 109.66 | Sell |
50-day EMA: | 106.19 | Buy |
200-day EMA: | 104.21 | Buy |
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. Earnings Growth & AEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |